A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
暂无分享,去创建一个
Yan Liu | William R. Schief | Ryan McBride | Robyn L. Stanfield | Andrew B. Ward | Chi-Huey Wong | William C. Olson | Ten Feizi | Dennis R. Burton | Pascal Poignard | Ian A. Wilson | Yukishige Ito | Cassandra Ogohara | James C. Paulson | John P. Moore | D. Burton | I. Wilson | Chi‐Huey Wong | Po-Ssu Huang | W. Schief | A. Ward | L. Walker | J. Julien | P. Poignard | R. Stanfield | A. Cupo | R. Sanders | R. Khayat | J. Paulson | M. Crispin | Cassandra Ogohara | R. Depetris | R. Pejchal | A. Marozsan | W. Olson | K. Doores | R. McBride | Yukishige Ito | Sheng-Kai Wang | Po-Ssu Huang | Max Crispin | Rogier W. Sanders | Reza Khayat | Christopher N. Scanlan | A. Ramos | T. Feizi | Yan Liu | Sheng-Kai Wang | Jean-Philippe Julien | Robert Pejchal | Laura M. Walker | Katie J. Doores | Andre Marozsan | Albert Cupo | Alejandra Ramos | Rafael Depetris | Umesh Katpally | Sebastien Maloveste | Sebastien M. Maloveste | U. Katpally | Ryan McBride
[1] J. Ashby. References and Notes , 1999 .
[2] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[3] T. Pierson,et al. A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus , 2011, PLoS pathogens.
[4] J. L. Smith,et al. Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution. , 1987, Journal of molecular biology.
[5] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[6] I. Wilson,et al. An Insertion Mutation That Distorts Antibody Binding Site Architecture Enhances Function of a Human Antibody , 2011, mBio.
[7] Robyn L Stanfield,et al. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. , 2004, Structure.
[8] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[9] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[10] Christopher Irving,et al. Appion: an integrated, database-driven pipeline to facilitate EM image processing. , 2009, Journal of structural biology.
[11] Martin Phillips,et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[12] John P. Moore,et al. Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A. , 2006, AIDS research and human retroviruses.
[13] John P. Moore,et al. Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[14] David C Montefiori,et al. Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. , 2010, Virology.
[15] R. Dwek,et al. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. , 2010, Glycobiology.
[16] Randy J Read,et al. Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .
[17] G. Bricogne,et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. , 2004, Acta crystallographica. Section D, Biological crystallography.
[18] R. Dwek,et al. A statistical analysis of N- and O-glycan linkage conformations from crystallographic data. , 1999, Glycobiology.
[19] N. Grigorieff,et al. Accurate determination of local defocus and specimen tilt in electron microscopy. , 2003, Journal of structural biology.
[20] J. L. Raina,et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. , 1992, Virology.
[21] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[22] Virginia Pascual,et al. Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes , 1998, The Journal of experimental medicine.
[23] D. Erwin,et al. The Cambrian Explosion: The Construction of Animal Biodiversity. , 2013 .
[24] Chi-Huey Wong,et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Donnenberg,et al. Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes. , 2003, Methods.
[26] P. Klasse. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. , 2007, Virology.
[27] E. Rosenberg,et al. Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals , 2011, Journal of Virology.
[28] Michael J Taussig,et al. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. , 2007, Journal of molecular biology.
[29] Dennis R. Burton,et al. A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals , 2010, PLoS pathogens.
[30] M L Connolly,et al. The molecular surface package. , 1993, Journal of molecular graphics.
[31] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[32] Sriram Subramaniam,et al. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures , 2011, Proceedings of the National Academy of Sciences.
[33] Pamela J. Bjorkman,et al. Few and Far Between: How HIV May Be Evading Antibody Avidity , 2010, PLoS pathogens.
[34] S. Gordon,et al. Ligands for the β-Glucan Receptor, Dectin-1, Assigned Using “Designer” Microarrays of Oligosaccharide Probes (Neoglycolipids) Generated from Glucan Polysaccharides* , 2006, Journal of Biological Chemistry.
[35] Philip G. Evans,et al. Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions. , 2007, Chemistry & biology.
[36] L. Morris,et al. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.
[37] W Chiu,et al. EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.
[38] Chi-Huey Wong,et al. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.
[39] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[40] Ewa Folta-Stogniew,et al. Oligomeric states of proteins determined by size-exclusion chromatography coupled with light scattering, absorbance, and refractive index detectors. , 2006, Methods in molecular biology.
[41] J. L. Le Doux,et al. Kinetics of retrovirus production and decay. , 1999, Biotechnology and bioengineering.
[42] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[43] D. Burton,et al. Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1 , 2010, Proceedings of the National Academy of Sciences.
[44] A. M. Lawson,et al. Neoglycolipid technology: deciphering information content of glycome. , 2003, Methods in enzymology.
[45] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[46] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[47] Yukishige Ito,et al. Synthesis of an octamannosyled glycan chain, the key oligosaccharide structure in ER-associated degradation. , 2003, Carbohydrate research.
[48] Dennis R. Burton,et al. Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 , 2010, Journal of Virology.
[49] Q. Sattentau,et al. Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.
[50] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[51] J. Binley,et al. Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins , 2002, Journal of Virology.
[52] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[53] D. Burton,et al. The antiviral activity of antibodies in vitro and in vivo , 2001, Advances in Immunology.
[54] A. West,et al. Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10 , 2009, Proceedings of the National Academy of Sciences.
[55] J. Binley,et al. A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure , 2000, Journal of Virology.
[56] I. Wilson,et al. A Trojan horse with a sweet tooth , 1995, Nature Structural Biology.
[57] Chao Yang,et al. SPARX, a new environment for Cryo-EM image processing. , 2007, Journal of structural biology.
[58] Renate Kunert,et al. Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies , 2004, Journal of Virology.
[59] E. Toone. Structure and energetics of protein-carbohydrate complexes , 1994 .
[60] Axel T Brunger,et al. Considerations for the refinement of low-resolution crystal structures. , 2006, Acta crystallographica. Section D, Biological crystallography.
[61] Yukishige Ito,et al. High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates. , 2006, Bioorganic & medicinal chemistry.
[62] Martin Frank,et al. Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB , 2004, Nucleic Acids Res..
[63] Wen Jiang,et al. EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.
[64] D R Burton,et al. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.
[65] G. Sapiro,et al. Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.
[66] R. Wyatt,et al. Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage. , 2005, Virology.
[67] J. Sodroski,et al. Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State , 2009, PLoS pathogens.
[68] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[69] M Radermacher,et al. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. , 2009, Journal of structural biology.
[70] T. Pierson,et al. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. , 2008, Virology.
[71] A. Trkola,et al. MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1 , 2011, The Journal of experimental medicine.
[72] Roland Contreras,et al. Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[73] Q. Sattentau,et al. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer , 1995, The Journal of experimental medicine.